XML 23 R8.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
12 Months Ended
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2019
USD ($)
Cash flow from operating activities:      
Net income $ 88,282,828 $ 28,157,478 $ 37,235,134
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss on sale of discontinued operations 0 0 38,377,623
Loss on assets held for sale 37,579 251,263 0
Amortization of intangible assets 5,474,240 5,010,626 1,527,656
Amortization of historic tax credits 1,736,384 868,192 0
Amortization of debt issuance costs 659,292 517,499 592,549
Provision for credit losses 86,244,714 181,730,182 148,426,578
Depreciation 6,945,581 7,147,966 6,608,348
Loss on sale of property and equipment 2,812,404 339,259 93,199
Deferred income tax expense (benefit) 5,651,362 572,914 (3,655,751)
Compensation related to stock option and restricted stock plans, net of taxes and adjustments 19,281,278 28,952,161 17,635,309
Gain on sale of finance receivables (24,667) 0 0
Gain on company-owned life insurance 1,064,897 0 0
Change in accounts:      
Other assets, net (4,828,957) (9,470,838) (5,507,068)
Income taxes payable and receivable 6,610,559 (6,584,895) (2,547,222)
Accounts payable and accrued expenses (18,258,393) 19,917,429 5,877,916
Net cash provided by operating activities 199,559,307 257,409,236 244,664,271
Cash flows from investing activities:      
Increase in loans receivable, net (29,343,372) (183,482,267) (190,976,279)
Net assets acquired from business combinations and asset acquisitions, primarily loans (15,210,973) (47,100,694) (33,922,279)
Increase in intangible assets from acquisitions (4,563,280) (14,455,278) (10,223,508)
Purchases of property and equipment (11,683,857) (11,277,780) (9,805,084)
Proceeds from sale of property and equipment 346,943 284,869 466,806
Proceeds from the sale of assets held for sale 2,810,391 0 0
Proceeds from the sale of finance receivables 449,327 0 0
Proceeds from sale of discontinued operations 0 0 37,494,505
Proceeds from company-owned life insurance 1,997,279 0 0
Net cash used in investing activities (55,197,542) (256,031,150) (206,965,839)
Cash flow from financing activities:      
Borrowings from senior notes payable 310,984,250 540,691,400 364,290,000
Payments on senior notes payable (357,076,750) (341,531,400) (357,250,000)
Debt issuance costs associated with senior notes payable (784,250) (991,400) (240,000)
Proceeds from exercise of stock options 12,268,554 4,612,926 5,997,948
Payments for taxes related to net share settlement of equity awards (3,173,735) (4,476,159) (1,394,835)
Repurchase of common stock (102,452,302) (197,399,964) (74,519,863)
Excess tax expense from exercise of stock options 0 0 0
Net cash provided by (used in) financing activities (140,234,233) 905,403 (63,116,750)
Effects of foreign currency fluctuations on cash and cash equivalents 0 0 2,667,447
Net change in cash and cash equivalents 4,127,532 2,283,489 (22,750,871)
Cash and cash equivalents at beginning of year from continuing operations 11,618,922 9,335,433 12,473,833
Cash and cash equivalents at beginning of year from discontinued operations 0 0 19,612,471
Cash and cash equivalents at end of year 15,746,454 11,618,922 9,335,433
Cash and cash equivalents at end of year from continuing operations 15,746,454 11,618,922 9,335,433
Cash and cash equivalents at end of year from discontinued operations   0 0
Supplemental Disclosures:      
Interest paid during the year 24,993,898 23,942,122 16,835,789
Income taxes paid during the year $ 14,857,555 $ 15,711,692 $ 23,259,590